Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC) - Maughan, B L; Suzman, D L; Nadal, R M (J Clin Oncol, 2016)
(suppl 2S; abstr 308)